CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455 | -74.6% | 15,450 | -60.5% | 0.02% | -78.8% |
| Q4 2022 | $1,794 | -99.9% | 39,143 | 0.0% | 0.10% | -13.9% |
| Q3 2022 | $1,896,000 | +45.3% | 39,143 | +17.8% | 0.12% | +17.3% |
| Q2 2022 | $1,305,000 | +7.9% | 33,226 | +1.1% | 0.10% | +24.1% |
| Q1 2022 | $1,210,000 | +440.2% | 32,868 | +568.0% | 0.08% | +182.1% |
| Q4 2021 | $224,000 | -70.6% | 4,920 | -86.6% | 0.03% | -87.1% |
| Q4 2020 | $762,000 | +364.6% | 36,684 | +155.0% | 0.22% | +255.7% |
| Q3 2019 | $164,000 | -66.5% | 14,388 | -80.3% | 0.06% | -77.6% |
| Q3 2015 | $490,000 | -0.4% | 73,181 | 0.0% | 0.27% | +0.4% |
| Q2 2015 | $492,000 | -0.8% | 73,181 | 0.0% | 0.27% | -1.5% |
| Q1 2015 | $496,000 | -20.5% | 73,181 | -6.0% | 0.28% | -25.7% |
| Q4 2014 | $624,000 | +511.8% | 77,850 | +169.0% | 0.37% | +386.8% |
| Q3 2014 | $102,000 | +8.5% | 28,940 | +46.5% | 0.08% | +24.6% |
| Q2 2014 | $94,000 | – | 19,750 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |